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Conclusion: Severe reductions in target dose coverage were 
observed as an effect of interfractional anatomical changes. 
The difference between the position verification methods 
was a lesser issue compared to the effect of the anatomical 
changes. 
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Purpose or Objective: The new ESTRO consensus guideline 
for target delineation for elective breast radiotherapy 
(Offersen Radiother Oncol. 2015) establish the humeral head 
and connective tissues 10 mm around it as Planning Risk 
Volume (PRV). The objective was to implement these 
guidelines for sparing the humeral head in elective breast 
radiotherapy with level 1 and 2 (L1/L2) lymph nodes by 
comparing three different planning techniques. 
 
Material and Methods: Ten patients with left-sided breast 
cancer were enrolled in a planning study performed in 
Pinnacle3 v9.8 (Philips). All patients were planned with 16 x 
2.66Gy on the breast (PTVp) and the elective L1/L2 lymph 
nodes (PTVn). We compared three techniques: IMRT with high 
tangential field (HTF), 6-field IMRT and VMAT. The humeral 
head PRV (hh+10) was included with an objective of V40Gy < 
1cc for all three techniques. Treatment plans were obtained 
with the inverse planning tool and optimization was achieved 
by decreasing the dose to the organs at risk (OARs; lungs, 
heart and right breast) as low as possible while maintaining a 
PTVp V95% of 97% and PTVn V90% of 95%.  
For the high tangential fields, the cranial border of the fields 
was extended to include PTVn. The leaves of the 5 mm multi 
leaf collimator were then closed to exclude hh+10 to reduce 
the dose to the humeral head and the surrounding tissue. 
This technique is currently used in our clinic. The 6-field 
IMRT technique consisted of tangential fields and four 
additional fields (at 330, 20, 80 and 170 degrees) to ensure 
proper coverage of the cranial part of the breast and the 
lymph nodes. The cranial border of the tangential fields and 
caudal border of the four additional fields was set 1cm below 
the attachment of the clavicle at the sternum. The third 
technique was a VMAT dualarc from 305 to 180 degrees.  
 
Results: HTF resulted in an average PTVp V95% of 97.2% and 
an average PTVn V90% of 90.4% (see Table 1). With the 
additional fields of the 6-field IMRT technique, the coverage 
of the lymph nodes increased significantly to on average 
98.0% (p = 0.01) while PTVp did not vary significantly (p = 
0.92). The doses to the OAR were comparable between the 
HTF and IMRT technique. The coverage of PTVn increased 
when using VMAT to an average of 99.5% (p < 0.01 compared 
to HTF and p = 0.19 compared to IMRT). The dose to the OAR 
increased as well. The mean dose to the contralateral breast 
increased significantly from 0.6Gy with HTF and IMRT to 
2.3Gy with VMAT (p < 0.01 for both). 
 
 
 
Conclusion: The humeral head and surrounding tissues as 
defined in the new ESTRO guideline can be spared with the 6-
field IMRT or VMAT technique. It is not possible through high 
tangential fields without reducing PTVn coverage.  
A 6-field IMRT technique including tangential fields and four 
additional fields to cover the lymph nodes and the cranial 
part of the breast leads to adequate coverage of the primary 
target and the lymph nodes without increasing the dose to 
the other OARs. 
 
PO-0848  
Simultaneous integrated protection (SIP): a new concept 
for high precision radiation therapy 
T. Brunner
1Universitätsklinik Freiburg, Department of Radiation 
Oncology, Freiburg, Germany 
1, S. Adebahr1, E. Gkika1, A. Zipfel1, R. Wiehle1, U. 
Nestle1, A. Grosu1 
 
Purpose or Objective: Stereotactic radiotherapy near critical 
serial organs at risk (OAR) requires specific caution to avoid 
severe toxicity. Current strategies are to (1) to rule out SBRT 
as a treatment option, (2) to use full dose SBRT and expose 
patients to higher risks, (3) to homogenously underdose the 
entire planning target volume (PTV), or (4) to trim PTV 
margins individually and non-quantifiably. We here describe a 
novel IMRT prescription method termed simultaneous 
integrated protection (SIP) for quantifiable and comparable 
dose prescription to targets very close to dose limiting 
structures. This work will be focussed on the planning of 
SBRT. 
 
Material and Methods: For patients with infringement of 
dose constraints to at least one serial OAR, e.g. central 
airways, bowel, we defined a planning risk volume (PRV). The 
intersection volume of the PRV with the total planning target 
volume (PTV_Σ) was defined as the protection PTV_SIP and 
the vast non-intersecting majority of PTV_Σ as the dominant 
PTV (PTV_dom). Radiotherapy treatment planning was 
performed using IMRT. Dose was prescribed to PTV_dom 
according to ICRU in 3, 5, 8 or 12 fractions. If in doubt, 
preference to a higher number of fractions was given as a 
function of the size of PTV_SIP. D_max was allowed to be up 
to 130% of the prescribed dose. No specific dose was 
prescribed to the PTV_SIP but dose was required to stay just 
within the constraints for the respective OAR. Dose-volume-
histogram (DVH) analysis was based on absolute volumes of 
OARs, not on PRVs. 
 
Results: This method led to a fall off region within PTV_SIP 
between the PTV_dom and the OAR. We here demonstrate 
this approach for six patients. Two had lesions in the chest, 
one in the liver, two in the pancreas and one in the left 
kidney (Figure 1). Size of the PTVs (PTV_Σ) ranged from 14.5 
to 84.9 mL (median 49.2 mL, mean 49.7 mL; Figure 2). Sizes 
of PTV protection subvolumes (PTV_SIP) ranged from 1.8 – 3.9 
mL (median and mean 2.8 mL). Relative PTV_SIP ranged from 
2.9% - 13.4% of the size of PTV_Σ (median 7.4%). Noteworthy, 
the largest ratio, 13.4%, was an absolute volume of 2 mL, 
only. D_min of the PTV_SIP was significantly lower in patients 
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1, 2 and 6 due to air within the PTV_SIP volumes compared 
with the other patients. Safety of the plans was analysed 
from the absolute volume DVHs (dose to mL). The steepness 
of dose fall off could be read off by the comparing the doses 
to the PRVs with those to the OARs. The constraints were 
respected for the corresponding OARs. All patients had local 
control at a median follow-up of 9 months and toxicity was 
low. 
 
Conclusion: SIP-IMRT is shown to result in a median dose of 
≥100% to PTV_Σ, to achieve high local control and low 
toxicity. Longer follow-up is required for verification of these 
results and a prospective clinical trial is currently testing this 
new approach in chest and abdomen SBRT. 
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Purpose or Objective: Within the frame of further 
implementing a precise dose delivery in young patients with 
mediastinal Hodgkin lymphoma, heart sparing appears a 
crucial endpoint. Recent studies demonstrated a correlation 
between the occurrence of various late events (e.g. heart 
failure, myocardial infarction, valve disease) and the dose 
received by different cardiac substructures, giving insights 
into a complex mechanism of radiation-induced toxicity. The 
purpose of this study was to compare the dose received by 
these substructures either using an optimized multi-arcs 
volumetric arc therapy (VMAT) or classical 3D-CRT.  
 
Material and Methods: We analyzed the plans of 14 patients 
(3 males and 11 females) with stage I-IIA mediastinal disease 
without axillary involvement, treated with involved site 
radiotherapy; 11 had a bulky presentation at diagnosis. In 
every patient, a deformable fusion was performed with a 
dedicated software (Velocity™, Varian) between the planning 
CT scan and the pre-radiotherapy contrast enhanced CT scan. 
The following structures were delineated: whole heart; left 
main, left descending, circumflex and right coronary arteries; 
aortic, pulmonary, mitral and tricuspid valves; right and left 
atria; right ventricle, left ventricle and inter-ventricular 
septum; left ventricular apex, mid cavity, base and lateral 
wall. Two experienced radiation oncologists contoured target 
volumes (CTV) and heart structures, after a training session 
with a cardiologist and a heart radiologist. 3DCRT was 
planned as AP-PA, while the VMAT approach consisted of 
multi non-coplanar arcs (the so-called butterfly technique). 
Mean and max dose received by the single substructures were 
compared by Student’s T test.  
 
Results: Mean and max doses for the different cardiac 
structures,, according to the technique used, are reported in 
table 1. Maximum dose resulted similar for almost all the 
structures except for the whole heart and the right ventricle, 
where VMAT gave higher doses (probably due to small 
hotspots in the PTV areas adherent to heart segments, mainly 
located in the lower anterior mediastinum). Conversely, a 
lower mean dose was delivered by using VMAT to all 
structures, reaching a strong significant difference for whole 
heart (p = 0.025), aortic valve (p<0.0001), mitral valve 
(p=0.049) and left atrium (p<0.0001). Most significant 
findings are illustrated in figure 1.  
 
 
 
 
 
Conclusion: In this preliminary dosimetric comparison, 
optimized multi arcs VMAT was able to significantly reduce 
the mean dose to crucial heart substructures such as aortic 
valve, with a generalized reduction in mean doses received 
